| Product Code: ETC9222863 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia mRNA Vaccine and Therapeutics Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia mRNA Vaccine and Therapeutics Market - Industry Life Cycle |
3.4 Serbia mRNA Vaccine and Therapeutics Market - Porter's Five Forces |
3.5 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.8 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Serbia mRNA Vaccine and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government funding and support for mRNA vaccine research and development in Serbia |
4.2.2 Growing prevalence of infectious diseases and the need for advanced vaccines |
4.2.3 Rising investments in healthcare infrastructure and technology in Serbia |
4.3 Market Restraints |
4.3.1 Regulatory challenges and approval processes for mRNA vaccines in Serbia |
4.3.2 Limited awareness and acceptance of mRNA therapeutics among healthcare professionals and the general population |
5 Serbia mRNA Vaccine and Therapeutics Market Trends |
6 Serbia mRNA Vaccine and Therapeutics Market, By Types |
6.1 Serbia mRNA Vaccine and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Self-amplifying mRNA-based Vaccines, 2021- 2031F |
6.1.4 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Conventional Non-amplifying mRNA-based Vaccines, 2021- 2031F |
6.2 Serbia mRNA Vaccine and Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cancer, 2021- 2031F |
6.2.3 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.4 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Autoimmune Diseases, 2021- 2031F |
6.2.5 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.3 Serbia mRNA Vaccine and Therapeutics Market, By Treatment Type |
6.3.1 Overview and Analysis |
6.3.2 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Monoclonal Antibody, 2021- 2031F |
6.3.3 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Gene Therapy, 2021- 2031F |
6.3.4 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Cell Therapy, 2021- 2031F |
6.3.5 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Other, 2021- 2031F |
6.4 Serbia mRNA Vaccine and Therapeutics Market, By End user |
6.4.1 Overview and Analysis |
6.4.2 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Research Laboratories and Organizations, 2021- 2031F |
6.4.3 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.4 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.5 Serbia mRNA Vaccine and Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Serbia mRNA Vaccine and Therapeutics Market Import-Export Trade Statistics |
7.1 Serbia mRNA Vaccine and Therapeutics Market Export to Major Countries |
7.2 Serbia mRNA Vaccine and Therapeutics Market Imports from Major Countries |
8 Serbia mRNA Vaccine and Therapeutics Market Key Performance Indicators |
8.1 Number of research grants awarded for mRNA vaccine development in Serbia |
8.2 Percentage increase in healthcare spending allocated to mRNA vaccine and therapeutics research |
8.3 Number of clinical trials for mRNA vaccines conducted in Serbia |
9 Serbia mRNA Vaccine and Therapeutics Market - Opportunity Assessment |
9.1 Serbia mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Serbia mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Serbia mRNA Vaccine and Therapeutics Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.4 Serbia mRNA Vaccine and Therapeutics Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Serbia mRNA Vaccine and Therapeutics Market - Competitive Landscape |
10.1 Serbia mRNA Vaccine and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Serbia mRNA Vaccine and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here